CLCS — Cell Source Cashflow Statement
0.000.00%
- $0.03m
- -$12.18m
Annual cashflow statement for Cell Source, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -2.12 | -4.48 | -4.56 | -5.47 | -5.17 |
Depreciation | |||||
Non-Cash Items | -0.177 | 1.32 | 1.36 | 1.39 | 0.466 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.292 | 0.57 | 0.423 | 0.701 | 1.56 |
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Cash from Operating Activities | -2 | -2.59 | -2.77 | -3.38 | -3.14 |
Financing Cash Flow Items | 0.1 | 0.086 | -0.04 | -0.353 | -0.028 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1.65 | 2.6 | 2.99 | 3.23 | 3.27 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.352 | 0.009 | 0.217 | -0.152 | 0.13 |